Citropeptin
| Internal ID | 7089ada7-fc75-4389-a1f1-36385edd778c |
| Taxonomy | Organic acids and derivatives > Peptidomimetics > Depsipeptides > Cyclic depsipeptides |
| IUPAC Name | 2-[6-[(2E,6E)-4,6-dimethyl-5-oxoocta-2,6-dien-2-yl]-2-hydroxy-5-methyloxan-2-yl]-2-hydroxy-N-[7-hydroxy-20-(1-hydroxyethyl)-6-(methoxymethyl)-4-methyl-3-(2-methylpropyl)-2,5,8,15,19,22-hexaoxo-17-propan-2-yl-18-oxa-1,4,7,13,14,21,27-heptazatricyclo[21.4.0.09,14]heptacosan-16-yl]propanamide |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C50H82N8O15/c1-14-28(6)39(60)30(8)24-31(9)41-29(7)19-20-50(69,73-41)49(11,68)48(67)54-38-40(27(4)5)72-47(66)37(32(10)59)53-42(61)33-17-15-21-51-56(33)44(63)35(23-26(2)3)55(12)43(62)36(25-71-13)58(70)45(64)34-18-16-22-52-57(34)46(38)65/h14,24,26-27,29-30,32-38,40-41,51-52,59,68-70H,15-23,25H2,1-13H3,(H,53,61)(H,54,67)/b28-14+,31-24+ |
| InChI Key | HHBCEPSFYPJHIF-AIRRWTJMSA-N |
| Popularity | 4 references in papers |
| Molecular Formula | C50H82N8O15 |
| Molecular Weight | 1035.20 g/mol |
| Exact Mass | 1034.58996394 g/mol |
| Topological Polar Surface Area (TPSA) | 306.00 Ų |
| XlogP | 3.30 |
| Atomic LogP (AlogP) | 0.39 |
| H-Bond Acceptor | 17 |
| H-Bond Donor | 8 |
| Rotatable Bonds | 13 |
| 128554-13-2 |
| 2-[6-[(2E,6E)-4,6-dimethyl-5-oxoocta-2,6-dien-2-yl]-2-hydroxy-5-methyloxan-2-yl]-2-hydroxy-N-[7-hydroxy-20-(1-hydroxyethyl)-6-(methoxymethyl)-4-methyl-3-(2-methylpropyl)-2,5,8,15,19,22-hexaoxo-17-propan-2-yl-18-oxa-1,4,7,13,14,21,27-heptazatricyclo[21.4.0.09,14]heptacosan-16-yl]propanamide |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.6253 | 62.53% |
| Caco-2 | - | 0.8615 | 86.15% |
| Blood Brain Barrier | - | 0.8750 | 87.50% |
| Human oral bioavailability | - | 0.8286 | 82.86% |
| Subcellular localzation | Mitochondria | 0.4046 | 40.46% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8147 | 81.47% |
| OATP1B3 inhibitior | + | 0.9262 | 92.62% |
| MATE1 inhibitior | - | 0.9300 | 93.00% |
| OCT2 inhibitior | - | 0.9500 | 95.00% |
| BSEP inhibitior | + | 0.8922 | 89.22% |
| P-glycoprotein inhibitior | + | 0.7460 | 74.60% |
| P-glycoprotein substrate | + | 0.8594 | 85.94% |
| CYP3A4 substrate | + | 0.7504 | 75.04% |
| CYP2C9 substrate | - | 1.0000 | 100.00% |
| CYP2D6 substrate | - | 0.8816 | 88.16% |
| CYP3A4 inhibition | - | 0.8630 | 86.30% |
| CYP2C9 inhibition | - | 0.7513 | 75.13% |
| CYP2C19 inhibition | - | 0.7555 | 75.55% |
| CYP2D6 inhibition | - | 0.8865 | 88.65% |
| CYP1A2 inhibition | - | 0.7924 | 79.24% |
| CYP2C8 inhibition | + | 0.7856 | 78.56% |
| CYP inhibitory promiscuity | - | 0.9778 | 97.78% |
| UGT catelyzed | + | 0.8000 | 80.00% |
| Carcinogenicity (binary) | - | 0.8400 | 84.00% |
| Carcinogenicity (trinary) | Non-required | 0.4524 | 45.24% |
| Eye corrosion | - | 0.9790 | 97.90% |
| Eye irritation | - | 0.8996 | 89.96% |
| Skin irritation | - | 0.7496 | 74.96% |
| Skin corrosion | - | 0.9160 | 91.60% |
| Ames mutagenesis | - | 0.5700 | 57.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.6431 | 64.31% |
| Micronuclear | + | 0.7700 | 77.00% |
| Hepatotoxicity | + | 0.5949 | 59.49% |
| skin sensitisation | - | 0.8260 | 82.60% |
| Respiratory toxicity | + | 0.8000 | 80.00% |
| Reproductive toxicity | + | 0.9556 | 95.56% |
| Mitochondrial toxicity | + | 0.8750 | 87.50% |
| Nephrotoxicity | + | 0.4497 | 44.97% |
| Acute Oral Toxicity (c) | III | 0.5966 | 59.66% |
| Estrogen receptor binding | + | 0.8005 | 80.05% |
| Androgen receptor binding | + | 0.7584 | 75.84% |
| Thyroid receptor binding | + | 0.6428 | 64.28% |
| Glucocorticoid receptor binding | + | 0.7240 | 72.40% |
| Aromatase binding | + | 0.6383 | 63.83% |
| PPAR gamma | + | 0.8044 | 80.44% |
| Honey bee toxicity | - | 0.6644 | 66.44% |
| Biodegradation | - | 0.8000 | 80.00% |
| Crustacea aquatic toxicity | - | 0.5400 | 54.00% |
| Fish aquatic toxicity | + | 0.7132 | 71.32% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 99.41% | 97.25% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.54% | 96.09% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 98.53% | 90.08% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 98.52% | 85.14% |
| CHEMBL3837 | P07711 | Cathepsin L | 98.38% | 96.61% |
| CHEMBL2581 | P07339 | Cathepsin D | 98.26% | 98.95% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 97.81% | 94.45% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 97.07% | 91.11% |
| CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 96.72% | 92.88% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 95.35% | 95.71% |
| CHEMBL5966 | P55899 | IgG receptor FcRn large subunit p51 | 95.29% | 90.93% |
| CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 94.49% | 91.03% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 94.29% | 89.00% |
| CHEMBL332 | P03956 | Matrix metalloproteinase-1 | 94.09% | 94.50% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 94.02% | 97.09% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 93.52% | 89.50% |
| CHEMBL3524 | P56524 | Histone deacetylase 4 | 92.55% | 92.97% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 92.27% | 97.14% |
| CHEMBL218 | P21554 | Cannabinoid CB1 receptor | 91.99% | 96.61% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 91.48% | 96.47% |
| CHEMBL1902 | P62942 | FK506-binding protein 1A | 91.06% | 97.05% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 90.75% | 95.89% |
| CHEMBL2007 | P16234 | Platelet-derived growth factor receptor alpha | 90.59% | 91.07% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 89.79% | 98.59% |
| CHEMBL3976 | Q9UHL4 | Dipeptidyl peptidase II | 89.32% | 92.29% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 89.32% | 93.00% |
| CHEMBL4072 | P07858 | Cathepsin B | 89.10% | 93.67% |
| CHEMBL4073 | P09237 | Matrix metalloproteinase 7 | 88.82% | 97.56% |
| CHEMBL213 | P08588 | Beta-1 adrenergic receptor | 88.59% | 95.56% |
| CHEMBL3384 | Q16512 | Protein kinase N1 | 88.35% | 80.71% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 87.88% | 93.56% |
| CHEMBL5203 | P33316 | dUTP pyrophosphatase | 87.43% | 99.18% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 87.42% | 99.23% |
| CHEMBL1937 | Q92769 | Histone deacetylase 2 | 87.20% | 94.75% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 86.36% | 100.00% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 85.98% | 96.90% |
| CHEMBL1907601 | P11802 | Cyclin-dependent kinase 4/cyclin D1 | 85.38% | 98.99% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 85.35% | 95.50% |
| CHEMBL325 | Q13547 | Histone deacetylase 1 | 84.94% | 95.92% |
| CHEMBL4578 | Q14680 | Maternal embryonic leucine zipper kinase | 84.72% | 81.58% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 84.64% | 82.38% |
| CHEMBL4662 | P28074 | Proteasome Macropain subunit MB1 | 84.22% | 93.85% |
| CHEMBL3713062 | P10646 | Tissue factor pathway inhibitor | 84.04% | 97.33% |
| CHEMBL4303 | P08238 | Heat shock protein HSP 90-beta | 83.91% | 96.77% |
| CHEMBL1293267 | Q9HC97 | G-protein coupled receptor 35 | 83.86% | 89.34% |
| CHEMBL2563 | Q9UQL6 | Histone deacetylase 5 | 83.81% | 89.67% |
| CHEMBL4005 | P42336 | PI3-kinase p110-alpha subunit | 83.75% | 97.47% |
| CHEMBL3351 | Q13085 | Acetyl-CoA carboxylase 1 | 83.69% | 93.04% |
| CHEMBL3975 | P09467 | Fructose-1,6-bisphosphatase | 83.25% | 92.95% |
| CHEMBL5028 | O14672 | ADAM10 | 83.21% | 97.50% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 82.94% | 98.05% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 82.90% | 99.17% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 82.48% | 88.56% |
| CHEMBL5314 | Q06418 | Tyrosine-protein kinase receptor TYRO3 | 82.17% | 96.00% |
| CHEMBL2996 | Q05655 | Protein kinase C delta | 82.01% | 97.79% |
| CHEMBL2803 | P43403 | Tyrosine-protein kinase ZAP-70 | 80.84% | 82.50% |
| CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 80.09% | 98.75% |
| CHEMBL321 | P14780 | Matrix metalloproteinase 9 | 80.03% | 92.12% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| Hypericum prolificum |
| PubChem | 6444166 |
| LOTUS | LTS0116543 |
| wikiData | Q105205324 |